[RSS] Experimental drug slows progression of early Alzheimer's disease by 60%, study finds

[RSS]

Eli Lilly's experimental drug donanemab slowed the progression of Alzheimer's by 60% for patients in the earliest stages of the brain-wasting disease, according to trial data presented at a medical meeting on Monday. 

Source: https://www.france24.com/en/health/2023 ... tudy-finds